A Shift in Party Majority, a Shift in Priority? What the Pharmaceutical Industry Can Expect

The 2018 midterm elections are a few months behind us, with the Democrats now in control of the House of Representatives and the Republicans maintaining their hold on the Senate. Hence, the future of the pharmaceutical industry—at least until the 2020 presidential election—is unclear. A split Congress does not necessarily offer any legislative certainties for the next 2 years, but it will shape the next 2 years of Mr Trump's presidency and provide the foundation for federal candidacy platforms in the 2020 presidential election.